Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC

2 Views· 08/31/23
OncLive® On Air
OncLive® On Air
0 Subscribers
0
In Drama

Dr Kelley discusses standard first-line treatment options for patients with advanced HCC, key findings from the phase 3 HIMALAYA trial, and the safety profile of the STRIDE regimen in this population.

Show more

 0 Comments sort   Sort By


Up next